Combining PARP inhibitor with TACC3 inhibition overcomes PARP inhibitor resistance in ovarian cancer

被引：0
|
作者：
Wu, Yu
Wang, Qilong
Deng, Chaolin
Li, Mo
Xiao, Yinan
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-4757
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4757
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [1] Combining PARP inhibitor with cMET Inhibition overcomes PARP inhibitor resistance in epithelial ovarian cancer.
    Kim, Min-Je
    Lee, Shin-Wha
    Lee, Young-Jae
    Park, Su-Bin
    Kang, Dong-Woo
    Kim, Yong-Man
    CANCER RESEARCH, 2022, 82 (12)
  • [2] Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models
    Kim, Hyoung
    Xu, Haineng
    George, Erin
    Hallberg, Dorothy
    Kumar, Sushil
    Jagannathan, Veena
    Medvedev, Sergey
    Kinose, Yasuto
    Devins, Kyle
    Verma, Priyanka
    Ly, Kevin
    Wang, Yifan
    Greenberg, Roger A.
    Schwartz, Lauren
    Johnson, Neil
    Scharpf, Robert B.
    Mills, Gordon B.
    Zhang, Rugang
    Velculescu, Victor E.
    Brown, Eric J.
    Simpkins, Fiona
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [3] Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models
    Hyoung Kim
    Haineng Xu
    Erin George
    Dorothy Hallberg
    Sushil Kumar
    Veena Jagannathan
    Sergey Medvedev
    Yasuto Kinose
    Kyle Devins
    Priyanka Verma
    Kevin Ly
    Yifan Wang
    Roger A. Greenberg
    Lauren Schwartz
    Neil Johnson
    Robert B. Scharpf
    Gordon B. Mills
    Rugang Zhang
    Victor E. Velculescu
    Eric J. Brown
    Fiona Simpkins
    Nature Communications, 11
  • [4] Combining PARP inhibition with the polo-like kinase 1 (PLK1) inhibitor onvansertib overcomes PARP inhibitor resistance
    Chiappa, Michela
    Guffanti, Federica
    Decio, Alessandra
    Aliverti, Alessandro
    Ricci, Francesca
    Scanziani, Eugenio
    Camin, Federica
    Craparotta, Ilaria
    Barbera, Maria Chiara
    Bolis, Marco
    Ridinger, Maya
    Damia, Giovanna
    CANCER RESEARCH, 2022, 82 (12)
  • [5] Overcoming PARP inhibitor resistance in ovarian cancer
    Pina, Pamela Soberanis
    Lheureux, Stephanie
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (03) : 364 - 376
  • [6] Mechanisms of PARP inhibitor resistance in ovarian cancer
    Kubalanza, Kari
    Konecny, Gottfried E.
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2020, 32 (01) : 36 - 41
  • [7] Inhibition of ATR overcomes the PARP inhibitor resistance of BRCA-deficient cancer cells
    Yazinski, A.
    Zou, Lee
    CLINICAL CANCER RESEARCH, 2018, 24 (15) : 17 - 17
  • [8] Inhibition of TACC3 by a small molecule inhibitor in breast cancer
    Campo, Loredana
    Breuer, Eun-Kyoung
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 498 (04) : 1085 - 1092
  • [9] PARP Inhibitor Resistance and Acquired Vulnerability in Ovarian Cancer
    D'Andrea, Alan
    ONCOLOGIST, 2017, 22 : S1 - S1
  • [10] Diverse mechanisms of PARP inhibitor resistance in ovarian cancer
    Wakefield, Matthew John
    Nesic, Ksenija
    Kondrashova, Olga
    Scott, Clare L.
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2019, 1872 (02):
12345